Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SB3H
|
|||
| Drug Name |
PMID26924192-Compound-32
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
KYORIN PHARMACEUTICAL CO., LTD
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C32H38N6O3
|
|||
| Canonical SMILES |
CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCCC3)NC4=NC=C5C(=C4)N(C6=CC=CC=C6C(=O)N5C)C
|
|||
| InChI |
1S/C32H38N6O3/c1-4-41-29-19-22(31(39)38-17-13-23(14-18-38)37-15-7-8-16-37)11-12-25(29)34-30-20-27-28(21-33-30)36(3)32(40)24-9-5-6-10-26(24)35(27)2/h5-6,9-12,19-21,23H,4,7-8,13-18H2,1-3H3,(H,33,34)
|
|||
| InChIKey |
CBWCJYFVVHOTAZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bromodomain-containing protein 4 (BRD4) | Target Info | Inhibitor | [1] |
| Extracellular signal-regulated kinase 5 (ERK5) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Bromodomain-containing protein 4 (BRD4) | Target's Patent Info | [1] | |
| Extracellular signal-regulated kinase 5 (ERK5) | Target's Patent Info | [1] | ||
| WikiPathways | Chemical Compounds to monitor Proteins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.